AN ACT REQUIRING MANUFACTURERS OF BRAND NAME PRESCRIPTION DRUGS TO PROVIDE SAMPLES OF SUCH DRUGS TO MANUFACTURERS OF GENERIC PRESCRIPTION DRUGS.
To promote competition in the prescription drug market by allowing developers of generic drugs and biosimilar products to obtain reference samples.
Introduced by:General Law Committee
|New today||2-4 days old||5 days & older|
Add Notes to SB-48
Co-sponsors for Amendment LCO:
|3/20/2019||Referred to Joint Committee on General Law|
|3/19/2019||Drafted by Committee|
|3/5/2019||(GL)||Vote to Draft|
|2/15/2019||Public Hearing 02/19|
|1/31/2019||(GL)||Reserved for Subject Matter Public Hearing|
|1/22/2019||Change of Reference, House to Committee on General Law|
|1/22/2019||Change of Reference, Senate to Committee on General Law|
|1/18/2019||(PH)||Change of Reference General Law|
|1/15/2019||Referred to Joint Committee on Public Health|